Mitsui Chemicals will acquire shares and business assets of U.S. Ultradent Corporation for US$900 million, aiming to become a wholly owned subsidiary. The acquisition enhances dental materials business in the U.S. market and accelerates global expansion.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4183","jir_company_name":"Mitsui Chemicals, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-06-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/4183-20260612-01.pdf","jir_short_summary":"Mitsui Chemicals will acquire shares and business assets of U.S. Ultradent Corporation for US$900 million, aiming to become a wholly owned subsidiary. The acquisition enhances dental materials business in the U.S. market and accelerates global expansion.","jir_summary":"### Overview of the Acquisition\nMitsui Chemicals will acquire shares and business assets of Ultradent Corporation for US$900 million on June 12, 2026, with plans to make it a wholly owned subsidiary. Ultradent, based in Utah, USA, is a top global company in whitening and restorative materials. The acquisition aims to strengthen the oral care business in the U.S. market and accelerate global growth. Post-acquisition, Mitsui Chemicals will leverage synergies among its technologies and products along with Kulzer to provide comprehensive dental solutions.\n\n### Future Outlook and Impact\nThe specific impact of this acquisition on Mitsui Chemicals' performance is currently under review, but it is expected to contribute to long-term growth and improved profitability through expansion and synergy creation in the U.S. dental materials sector. The acquisition is scheduled to close in September 2026, and further details on synergies and business development will be announced separately.","jir_financial_highlights":"Acquisition Price: US$900 million (Unknown)\nUltradent Corporation Sales: US$372.1 million (+6.1% compared to December 2024)\nUltradent Corporation Net Assets: Unknown (Unknown)","jir_category":"","jir_hashtags":"#MitsuiChemicals, #M&A, #JapanStocks","jir_key_figures":"Acquisition Price: US$900 million\nUltradent Corporation Sales: US$372.1 million (fiscal year ending December 2025)\nPlanned Acquisition Date: September 2026","jir_meta_title":"[Mitsui Chemicals] Announces Acquisition of U.S. Dental Business | June 2026","jir_meta_description":"Mitsui Chemicals is acquiring shares and business assets of U.S. Ultradent Corporation for US$900 million to strengthen its global dental business. Stay tuned for future developments.","jir_og_title":"[Mitsui Chemicals] U.S. Dental Business Acquisition | June 2026","jir_og_description":"Mitsui Chemicals acquires U.S. Ultradent Corporation to accelerate global dental materials expansion. Details available in IR materials.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7672,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"m_and_a_alliance","footnotes":""},"sector":[],"importance":[],"class_list":["post-63925","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n